Disorders of Platelet Secretion Flashcards
most common of the hereditary platelet function defects
Storage pool and release reaction defects
Px with storage pool & release reaction defects present with:
mucocutaneous hemorrhage,
hematuria,
epistaxis,
easy and spontaneous bruising
Dense Granule Deficiencies
Hermansky-Pudlak syndrome
Chédiak-Higashi syndrome
Wiskott-Aldrich syndrome Thrombocytopenia–absent radius (TAR) syndrome
a-Granule Deficiencies
Gray platelet syndrome
dense granules are the storage site for:
serotonin
nucleotides (ADP & ATP)
calcium
pyrophosphate
Dense granule deficiencies can be subdivided into deficiency:
associated with albinism & nonalbinos
platelets of _ there is evidence for the presence of dense granule membranes in normal to near-normal numbers, which suggests that the disorder arises from an in- ability to package the dense granule contents
nonalbinos
plays a major role in platelet activation, recruitment, and aggregation and growth of the hemostatic plug
ADP
In the platelet function tests, addition of _ to platelet-rich plasma fails to induce an aggregation response from platelets with dense granule deficiency
arachidonic acid
characterized by tyrosinase- positive oculocutaneous albinism, defective lysosomal function in a variety of cell types, ceroid-like deposition in the cells of the reticuloendothelial system, and a profound platelet dense granule deficiency
Hermansky-Pudlak syndrome
Several of the mutations responsible for Hermansky-Pudlak syndrome have been mapped to _. Mutations in _ genes individually can give rise to Hermansky-Pudlak syndrome.
chromosome 19;
at least seven
most bleeding episodes in _ are not severe, lethal hemorrhage has been reported, and in one series hemorrhage accounted for 16% of deaths in affected patient
Hermansky-Pudlak syndrome
HPS
For extensive surgery or prolonged bleeding both _ & _ are required.
_ can be used to treat skin wounds that fail to spontaneously clot.
red blood cell (RBC) and platelet transfusions;
Thrombin-soaked Gelfoam
characterized by partial oculocutaneous albinism, frequent pyogenic bacterial infections, giant lysosomal granules in cells of hematologic and nonhematologic origin, platelet dense granule deficiency, and hemorrhage
Chédiak-Higashi syndrome
accompanied by severe immunologic defects and progressive neurologic dysfunction in patients who survive to adulthood
Chédiak-Higashi syndrome
The gene for the Chédiak-Higashi syndrome protein is located on
chromosome 1
disorder of generalized cellular dysfunction involving fusion of cytoplasmic granules;
marked by lymphocytic proliferation in the liver, spleen, and marrow with macro- phage accumulation in tissues.
Chédiak-Higashi syndrome
This is a rare X-linked disease caused by mutations in the WAS gene on the short arm of the _ that encodes for a 502-amino acid protein – the Wiskott-Aldrich syndrome protein (WASp) – that is found exclusively in hematopoietic cells, including lymphocytes
X chromosome Xp11.23
plays a crucial role in actin cytoskeleton remodeling
WASp
classic form of WAS characterized by susceptibility to infections associated with immune dysfunction, with recurrent bacterial, viral, and fungal infections, microthrom- bocytopenia, and severe eczema
eczema- thrombocytopenia immunodeficiency syndrome
Wiskott-Aldrich platelets are also structurally _. The number of dense granules is decreased, and the platelets are small (microthrombocytes)
abnormal
The platelets show a decreased aggregation response to ADP, collagen, and epinephrine and lack a secondary wave of aggregation in response to these agonists
Wiskott-Aldrich syndrome (WAS)
treatment for the thrombocytopenia!
splenectomy
platelet transfusion (hemorrhagic episodes)
bone marrow transplantation
congenital absence of the radial bones (the most pro- nounced skeletal abnormality), numerous cardiac and other skel- etal abnormalities, and thrombocytopenia (90% of cases)
Thrombocytopenia with absent radii syndrome (TAR)
are the storage site for proteins produced by the megakaryocyte (e.g., platelet-derived growth factor, thrombospondin, and platelet factor 4) or present in plasma and taken up by platelets
a-granules
lifelong mild bleeding tendencies, moderate thrombocytopenia, fibrosis of the marrow, and large platelets whose gray appearance on a Wright-stained blood film
Grey Platelet Syndrome
lifelong mild bleeding tendencies, moderate thrombocytopenia, fibrosis of the marrow, and large platelets whose gray appearance on a Wright-stained blood film:
More recently, a mutation in region 3p21.31 involving the gene _ has been identified. This gene is crucial for the devel- opment of !-granules.
Gray Platelet Syndrome
NBEAL2
in gray platelet syndrome, the plasma levels of _ and _ are increased, because although the proteins normally contained in !-granules are produced, storage in those granules is not possible
platelet factor 4 and B- thromboglobulin
Gray Platelet Syndrome Treatments:
platelet transfusions - severe bleeding
Cryoprecipitate - control bleeding
Desmopressin acetate - shorten the bleeding time
rare disorder in which both a-granules and dense granules are deficient
a -dense storage pool deficiency.
results from a deficiency of multimerin (a multi- meric protein that is stored complexed with factor V in a-granules)
Quebec platelet disorder